{
    "root": "3636693a-ba84-5d49-e063-6394a90a3006",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Indomethacin",
    "value": "20250528",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "INDOMETHACIN",
            "code": "XXE1CET956"
        }
    ],
    "indications": "indomethacin capsules indicated : moderate severe rheumatoid arthritis including acute flares chronic disease moderate severe ankylosing spondylitis moderate severe osteoarthritis acute painful shoulder ( bursitis and/or tendinitis ) acute gouty arthritis",
    "contraindications": "lowest effective shortest duration consistent individual patient treatment goals . ( 2.1 ) moderate severe rheumatoid arthritis including acute flares chronic disease ; moderate severe ankylosing spondylitis ; moderate severe osteoarthritis indomethacin capsules 25 mg two three times day . ( 2.2 ) acute painful shoulder ( bursitis and/or tendinitis ) 75 150 mg daily 3 4 divided doses . ( 2.3 ) acute gouty arthritis indomethacin capsules 50 mg three times day . ( 2.4 )",
    "warningsAndPrecautions": "indomethacin capsules , usp available containing either 25 mg indomethacin , usp . 25 mg capsule size ‘ 3 ’ two piece opaque green hard gelatin capsule imprinted ‘ g406 ’ body ‘ g ’ cap , filled white off-white granular powder . available follows : ndc : 70518-0254-00 packaging : 30 1 blister pack store 20°c 25°c ( 68°f 77°f ) [ usp controlled room temperature ] . protect light . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "indomethacin capsules contraindicated following patients : known hypersensitivity ( e.g . , anaphylactic serious skin ) indomethacin components product [ ( 5.7 , 5.9 ) ] . history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] . setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ] .",
    "indications_original": "Indomethacin capsules are indicated for:\n                  \n                     Moderate to severe rheumatoid arthritis including acute flares of chronic disease\n                     Moderate to severe ankylosing spondylitis\n                     Moderate to severe osteoarthritis\n                     Acute painful shoulder (bursitis and/or tendinitis)\n                     Acute gouty arthritis",
    "contraindications_original": "Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. ( 2.1 ) The dosage for moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis is indomethacin capsules 25 mg two or three times a day. ( 2.2 ) The dosage for acute painful shoulder (bursitis and/or tendinitis) is 75 to 150 mg daily in 3 or 4 divided doses. ( 2.3 ) The dosage for acute gouty arthritis is indomethacin capsules 50 mg three times a day. ( 2.4 )",
    "warningsAndPrecautions_original": "Indomethacin capsules, USP are available containing either 25 mg of indomethacin, USP.\n                  The 25 mg capsule is a size ‘3’ two piece opaque green hard gelatin capsule imprinted with ‘G406’ on the body and ‘G’ on the cap, filled with white to off-white granular powder. They are available as follows:\n                  NDC: 70518-0254-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].\n                  Protect from light.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Indomethacin capsules are contraindicated in the following patients:\n                  \n                     Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product\n  \n   [see Warnings and Precautions (\n   \n    5.7,\n   \n    5.9)]\n  \n   .\n \n  \n                     History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients\n  \n   [see Warnings and Precautions (\n   \n    5.7,\n   \n    5.8)]\n  \n   .\n \n  \n                     In the setting of coronary artery bypass graft (CABG) surgery\n  \n   [see Warnings and Precautions (\n   \n    5.1)]."
}